FMC (FMC) said Monday it agreed to collaborate with Bayer to commercialize products containing Isoflex active in the EU and the UK.

Under the deal, both companies will bring the products to the winter cereal and oilseed rape markets.

Financial terms of the partnership were not disclosed.

Registration of Isoflex active in the EU is expected in 2025, pending regulatory approvals, according to FMC.